Cuu Long Pharmaceutical JSC

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 21.27% vs -9.15% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -470.51% vs 124.06% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "285,741.00",
          "val2": "235,615.30",
          "chgp": "21.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13,136.10",
          "val2": "8,951.70",
          "chgp": "46.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12,952.70",
          "val2": "5,979.60",
          "chgp": "116.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5,792.90",
          "val2": "1,563.50",
          "chgp": "-470.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2.10%",
          "val2": "-2.50%",
          "chgp": "0.04%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 14.24% vs 12.63% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -12.86% vs -44.97% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,306,797.40",
          "val2": "1,143,946.30",
          "chgp": "14.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "98,087.70",
          "val2": "109,004.10",
          "chgp": "-10.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "25,494.50",
          "val2": "30,530.50",
          "chgp": "-16.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "54,145.50",
          "val2": "62,134.40",
          "chgp": "-12.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "45.80%",
          "val2": "61.80%",
          "chgp": "-1.60%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

285,741.00

235,615.30

21.27%

Operating Profit (PBDIT) excl Other Income

13,136.10

8,951.70

46.74%

Interest

12,952.70

5,979.60

116.61%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-5,792.90

1,563.50

-470.51%

Operating Profit Margin (Excl OI)

-2.10%

-2.50%

0.04%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 21.27% vs -9.15% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is -470.51% vs 124.06% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,306,797.40

1,143,946.30

14.24%

Operating Profit (PBDIT) excl Other Income

98,087.70

109,004.10

-10.01%

Interest

25,494.50

30,530.50

-16.49%

Exceptional Items

0.00

0.00

Consolidate Net Profit

54,145.50

62,134.40

-12.86%

Operating Profit Margin (Excl OI)

45.80%

61.80%

-1.60%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 14.24% vs 12.63% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -12.86% vs -44.97% in Dec 2023

All Annual Results